(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Timothy Busfield turns himself in to face child sexual abuse charges in New Mexico - 210 Distinct Kinds of Chinese Neighborhood Specialty Hot Pot
- 3Several injured as man threatens attack on German high-speed train
- 4Which Exhibition hall Do You Suggest? Vote
- 5Marvel's X-Men are joining the battle in 'Avengers: Doomsday': Watch the teaser
- 5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- Survey: Protected And Versatile Men's Razor
- Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
- Pope Leo XIV calls for urgent climate action and says God’s creation is 'crying out'
- Idris Elba is the king of the stress-watch
- Israeli president concerned over proposed renaming of park
- The Rhythms of the Street: Shipping's Tune in the Economy's Symphony
- US FDA grants market authorization to six on! PLUS nicotine pouch products
- Vote in favor of the handheld vacuum that you love for its strong attractions!
